U.S. copycat GLP-1s trigger sharp market correction Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, lost more than €60 billion in market value in a single day. The
News
1Article
U.S. copycat GLP-1s trigger sharp market correction Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, lost more than €60 billion in market value in a single day. The